HFC-134a in Cars - Can it make you Crash?

Ian Maclaine-cross, 7th October 1997

In a preliminary report of the 19th August 1997, Vinegar and others describe the effects of inhaling refrigerants 1301, 134a and 227ea at the USAF Medical Center, Wright-Patterson AFB, Ohio. The seven human subjects were healthy male volunteers with ages from 21 to 49. All subjects showed no adverse affects when breathing through the apparatus pure air or 0.5% by volume R-1301 in air for 30 minutes and none were expected for R-134a.

After 4.5 minutes of breathing R-134a at 0.4% by volume in air, subject three lost consciousness and both pulse and blood pressure dropped to zero. Medical personnel restored pulse and blood pressure and administered 100% oxygen. Vital signs returned to pre-exposure values after approximately one hour. After 10.5 minutes breathing 0.4% R-134a, subject five's blood pressure and pulse rose rapidly and the exposure was terminated. After one hour breathing room air and then only 2.5 minutes breathing 0.2% R-134a, subject five's blood pressure and pulse again rose rapidly and exposure was terminated. These were the only two subjects exposed to R-134a. Both subjects were still reporting problems with dizziness and balance six weeks after the exposure.

In The Lancet of the 23rd August 1997, Hoet and others describe an epidemic of liver disease in nine Belgian crane drivers. In March 1996, R-114 had been replaced in the air conditioning system of the crane cabin by a mixture of R-123 and R-124. At the end of April one of the drivers became progressively ill and was admitted to hospital with acute hepatitis. At the end of June he returned to work but within a week returned ill to hospital. Another driver developed acute hepatitis in May and a third was admitted to hospital in July. Six additional drivers developed symptoms of hepatitis. An inspection in July revealed a refrigerant leak into the cabin and after repairs in August no recurrences or new cases of liver diseases were recorded. Clinical tests on blood and a biopsy also indicated refrigerant as the cause. Similar disease has been observed in humans exposed to halothane and in animals exposed to R-123. The concentration the crane drivers were exposed to must have been of the order of 0.002% by volume since the leak occurred over four months.

In 1995, a technician in Brisbane Australia accidently exposed for about a minute to an R-134a concentration of about 2% had to recover in hospital. In 1996, a taxi-driver with a slowly leaking air-conditioner in the same city complained of feeling ill, recovered when he took a week off, got sick again when he returned to work and had no further symptoms when the evaporator was repaired.

Hoet and others (1997) suggest that metabolism to trifluoroacetic acid which modifies proteins causes the R-123 disease. Trifluoroacetic acid is also a decomposition product of R-134a but not of R-12 or R-1301 so the suggestion of Hoet and others may explain all the observations above.

The average exposure of refrigeration technicians to R-123 is much less than 0.002%, about 0.0001% and the peak during some procedures about 0.001% (NICNAS 1996). The exposure of car air-conditioner technicians to R-134a may be higher. These refrigerants are odorless so technicians rarely connect refrigerant exposure with any illness which occurs.

Sudden failure of air-conditioner components in car passenger compartments may occur as frequently as once in a million user years for some designs. Failures in cars retrofitted to R-134a could cause compartment concentration to exceed 0.4% by volume for over five minutes (Maclaine-cross 1997). The frequency of small pinhole and fatigue fracture leaks into the passenger compartment is of the order of once in a thousand user years. R-134a is original equipment on most cars manufactured after 1994. The toxicology data above suggests that leaks may cause driver errors resulting in personal injury and property damage.

The following precautions reduce R-134a risk to drivers, their passengers and the general public:-

* While the car is occupied, keep the compartment fan running or, in weather above freezing, wind down one window or the equivalent.

* If a fresh air vent control exists, keep it open at all times.

* If a refrigerant leak is noticed and the car is in motion, wind down the driver's window immediately and leave it open for at least an hour after the leak appears to cease.

* If a refrigerant leak is noticed and the car is stationary, immediately get out of the car or wind all windows down and keep them down for at least an hour after the leak appears to cease. If you must drive off, keep the driver's window open as above.

The ultimate solution is a non-toxic replacement refrigerant. Environmental laws make CFC-12 expensive in many countries. Many new blends contain components whose toxicology is now uncertain. The only replacement refrigerants known to be non-toxic are blends consisting of pure saturated hydrocarbons only, for example HC-12a (tm).

References

[DOC]article2.html 130K
Hoet, P., Graf, M.L.M., Bourdi, M., Pohl, L.R., Duray, P.H., Chen, W., Peter, R.M., Nelson, S.D., Verlinden, N. and Lison, D., Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons, The Lancet, Vol. 350, No. 9077, pp. 556-559, 23rd August, 1997.
[DOC]HCpapers.html 3K
Maclaine-cross, I. L., Refrigerant Concentrations in Car Passenger Compartments, Paper accepted for International Conference on Ozone Protection Technologies, Baltimore MD, November 12-13th, 1997.
(dead link) [DOC]Australian Government Publishing Service
NICNAS, 2,2-dichloro-1,1,1,-trifluoroethane (HFC-123), Priority Existing Chemical No.4, Full Public Report, National Industrial Chemicals Notification and Assessment Scheme, Australian Government Publishing Service, ISBN 0 644 45140 8, 119 p., March 1996.
[DOC]humanhal.pdf 4K disappeared from URL:
http://voyager.wpafb.af.mil/Publications/TechReports/humanhal.pdf on the morning of 30th September 1997.
Vinegar, A., Cook, R., McCafferty, J., Caracci, M. and Jepson, G., Human Inhalation of Halon 1301, HFC-134a and HFC-227ea for Collection of Pharmacokinetic Data, Report, Air Force Contract No. F41624-96-C-9010, Wright-Patterson AFB OH, 17 p., August 19th, 1997

Back to Index

Email comments on this page to: ian@ilm.mech.unsw.edu.au (Ian Maclaine-cross)